Radiofrequency Ablation Devices Market Size is Projected to Reach USD 10.21 Billion by 2030, Growing at a CAGR of 11%: Facts & Factors
January 24, 2023 04:00 ET | Facts & Factors
NEW YORK, US, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Radiofrequency Ablation Devices Market Size, Share, Growth Analysis Report By...
Chronic Venous Occlusions Treatment Market worth USD 9.5 billion by 2030, says Global Market Insights Inc.
November 23, 2022 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Chronic venous occlusions treatment market value is anticipated to exceed USD 9.5 billion by 2030, according to a new research report by...
Renal Denervation Market to Reach USD 4743.13 Million by 2030, with a CAGR of 40.7%. Rise in the Cases of Hypertension and CHF to Drive the Market
New York, United States, May 31, 2022 (GLOBE NEWSWIRE) -- RDN or Renal denervation is a minimally invasive procedure to treat resistant hypertension. This procedure implements Radiofrequency...
Radiofrequency Ablation Devices Market Size Worth $7,711.72 Million, Globally, by 2027 at 11.5% CAGR - Exclusive Report by The Insight Partners
December 16, 2021 07:41 ET | The Insight Partners
New York, Dec. 16, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Radiofrequency Ablation Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product...
vmr logo registered_ blue.png
Bone Tumor Ablation Devices Market size worth $ 344.89 Million, Globally, by 2028 at 8.21% CAGR: Verified Market Research®
November 15, 2021 11:15 ET | Verified Market Research
Jersey City, New Jersey, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Bone Tumor Ablation Devices Market” By End User (Hospitals, Ambulatory Surgical...
logo long.jpg
Global Interventional Oncology Ablation Market to Surpass US$ 766.6 Million by 2027, Says Coherent Market Insights (CMI)
August 19, 2021 08:40 ET | CMI
SEATTLE, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Global Interventional Oncology Ablation Market to Surpass US$ 766.6 Million by 2027, Says Coherent Market Insights (CMI) According to Coherent Market...
Global Radiofrequency Ablation Devices Market Analysis & Demand Report 2021-2030
June 21, 2021 04:13 ET | Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Radiofrequency Ablation Devices Market Research Report: By Component (Catheter Systems, Generators, Accessories), Application (Oncology, Cardiology,...
Celsion Corporation Receives Recommendation from Independent Data Monitoring Committee to Consider Stopping the Phase III OPTIMA Study
July 13, 2020 08:30 ET | Celsion CORP
Recommendation Based on DMC’s Finding Following the Second Pre-Planned Interim Analysis that the OPTIMA Study is Unlikely to Meet its Primary Efficacy Endpoint of Overall Survival Celsion...
Principal Investigator Professor Riccardo Lencioni Presents Celsion ThermoDox® Trial Data at SPECTRUM 2020 Interventional Oncology Conference
February 04, 2020 08:30 ET | Celsion CORP
Company reaffirms its projection for second pre-planned interim efficacy analysis for Phase III OPTIMA Study in the second quarter of 2020 LAWRENCEVILLE, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) --...
Celsion Co-sponsors Hepatocellular Carcinoma Symposium at the International Liver Cancer Association (ILCA) Annual Conference
September 23, 2019 08:00 ET | Celsion CORP
LAWRENCEVILLE, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug-development company, announces it co-sponsored a symposium focused on hepatocellular...